Global  

Novavax

Swedish clinical-stage vaccine company

Novavax    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19.

0
shares
ShareTweetSavePostSend
 

FDA fast tracks another possible COVID-19 vaccine [Video]

FDA fast tracks another possible COVID-19 vaccine

The Food and Drug Administration has given another possible COVID-19 vaccine fast track designation. The vaccine, produced by Novavax, will begin phase 3 clinical trials by the end of November. Story:..

Credit: ABC Action News     Duration: 01:43Published

You Might Like


India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla

SII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon.
DNA - Published

India's Serum says produced 40 million doses of AstraZeneca Covid-19 vaccine

Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential Covid-19 vaccine, and would soon begin making Novavax's rival..
IndiaTimes - Published

Scott Morrison gives an update on Australia's COVID-19 vaccine progress

Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian Government’s COVID-19 vaccine investment to more than $3.2 billion. Under the..
SBS - Published

Novavax aims for 2 billion Covid-19 vaccine doses with expanded India deal


IndiaTimes - Published

South Africa rolls out second coronavirus vaccine trial

south africa rolls out second coronavirus vaccine trial
Shares South Africa will launch clinical trials of a US-developed coronavirus vaccine with 2,900 volunteers this week, the second such study in the African country worst hit by the disease, lead..
WorldNews - Published

Novavax becomes fifth COVID-19 vaccine developer to release promising early results

The candidate vaccine seems to have generated an immune reaction similar to those in people who have recovered from COVID-19, the data shows.
USATODAY.com - Published

U.S. pumps $1.6 billion into Novavax’s COVID vaccine development

u.s. pumps $1.6 billion into novavax’s covid vaccine development
Novavax Inc., one of the front-runners in the race to develop a COVID-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest contribution yet from the Operation Warp Speed program...
WorldNews - Published

Novavax gets U.S. defense funding for its COVID-19 vaccine

Novavax Inc said on Thursday the U.S. Department of Defense (DoD) will give the late-stage biotech company up to $60 million to fund the manufacturing of its experimental COVID-19 vaccine.
Reuters - Published